2021-2027 Global and Regional Medical Marijuana Industry Status and Prospects Professional Market Research Report Standard Version
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The global Medical Marijuana market was valued at 4.04 Million USD in 2020 and will grow with a CAGR of 24.59% from 2020 to 2027, based on newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Scotts Miracle-Gro
Canopy Growth
GW Pharmaceuticals
Aurora Cannabis
Aphria
MedReLeaf
Insys Therapeutics
Sprott
CanniMed Therapeutics
Horizons Marijuana Life Sciences Index ETF
By Types:
Dried Flower
Oils + Concentrates
Softgel Capsules
By Applications:
Muscle Spasms
Nausea (from cancer chemotherapy)
Chronic Illness (HIV/Nerve Pain)
Seizure Disorders
Crohns Disease
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Medical Marijuana Market Size Analysis from 2022 to 2027
1.5.1 Global Medical Marijuana Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Medical Marijuana Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Medical Marijuana Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Medical Marijuana Industry Impact
Chapter 2 Global Medical Marijuana Competition by Types, Applications, and Top Regions and Countries
2.1 Global Medical Marijuana (Volume and Value) by Type
2.1.1 Global Medical Marijuana Consumption and Market Share by Type (2016-2021)
2.1.2 Global Medical Marijuana Revenue and Market Share by Type (2016-2021)
2.2 Global Medical Marijuana (Volume and Value) by Application
2.2.1 Global Medical Marijuana Consumption and Market Share by Application (2016-2021)
2.2.2 Global Medical Marijuana Revenue and Market Share by Application (2016-2021)
2.3 Global Medical Marijuana (Volume and Value) by Regions
2.3.1 Global Medical Marijuana Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Medical Marijuana Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Medical Marijuana Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Medical Marijuana Consumption by Regions (2016-2021)
4.2 North America Medical Marijuana Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Medical Marijuana Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Medical Marijuana Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Medical Marijuana Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Medical Marijuana Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Medical Marijuana Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Medical Marijuana Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Medical Marijuana Sales, Consumption, Export, Import (2016-2021)
4.10 South America Medical Marijuana Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Medical Marijuana Market Analysis
5.1 North America Medical Marijuana Consumption and Value Analysis
5.1.1 North America Medical Marijuana Market Under COVID-19
5.2 North America Medical Marijuana Consumption Volume by Types
5.3 North America Medical Marijuana Consumption Structure by Application
5.4 North America Medical Marijuana Consumption by Top Countries
5.4.1 United States Medical Marijuana Consumption Volume from 2016 to 2021
5.4.2 Canada Medical Marijuana Consumption Volume from 2016 to 2021
5.4.3 Mexico Medical Marijuana Consumption Volume from 2016 to 2021
Chapter 6 East Asia Medical Marijuana Market Analysis
6.1 East Asia Medical Marijuana Consumption and Value Analysis
6.1.1 East Asia Medical Marijuana Market Under COVID-19
6.2 East Asia Medical Marijuana Consumption Volume by Types
6.3 East Asia Medical Marijuana Consumption Structure by Application
6.4 East Asia Medical Marijuana Consumption by Top Countries
6.4.1 China Medical Marijuana Consumption Volume from 2016 to 2021
6.4.2 Japan Medical Marijuana Consumption Volume from 2016 to 2021
6.4.3 South Korea Medical Marijuana Consumption Volume from 2016 to 2021
Chapter 7 Europe Medical Marijuana Market Analysis
7.1 Europe Medical Marijuana Consumption and Value Analysis
7.1.1 Europe Medical Marijuana Market Under COVID-19
7.2 Europe Medical Marijuana Consumption Volume by Types
7.3 Europe Medical Marijuana Consumption Structure by Application
7.4 Europe Medical Marijuana Consumption by Top Countries
7.4.1 Germany Medical Marijuana Consumption Volume from 2016 to 2021
7.4.2 UK Medical Marijuana Consumption Volume from 2016 to 2021
7.4.3 France Medical Marijuana Consumption Volume from 2016 to 2021
7.4.4 Italy Medical Marijuana Consumption Volume from 2016 to 2021
7.4.5 Russia Medical Marijuana Consumption Volume from 2016 to 2021
7.4.6 Spain Medical Marijuana Consumption Volume from 2016 to 2021
7.4.7 Netherlands Medical Marijuana Consumption Volume from 2016 to 2021
7.4.8 Switzerland Medical Marijuana Consumption Volume from 2016 to 2021
7.4.9 Poland Medical Marijuana Consumption Volume from 2016 to 2021
Chapter 8 South Asia Medical Marijuana Market Analysis
8.1 South Asia Medical Marijuana Consumption and Value Analysis
8.1.1 South Asia Medical Marijuana Market Under COVID-19
8.2 South Asia Medical Marijuana Consumption Volume by Types
8.3 South Asia Medical Marijuana Consumption Structure by Application
8.4 South Asia Medical Marijuana Consumption by Top Countries
8.4.1 India Medical Marijuana Consumption Volume from 2016 to 2021
8.4.2 Pakistan Medical Marijuana Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Medical Marijuana Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Medical Marijuana Market Analysis
9.1 Southeast Asia Medical Marijuana Consumption and Value Analysis
9.1.1 Southeast Asia Medical Marijuana Market Under COVID-19
9.2 Southeast Asia Medical Marijuana Consumption Volume by Types
9.3 Southeast Asia Medical Marijuana Consumption Structure by Application
9.4 Southeast Asia Medical Marijuana Consumption by Top Countries
9.4.1 Indonesia Medical Marijuana Consumption Volume from 2016 to 2021
9.4.2 Thailand Medical Marijuana Consumption Volume from 2016 to 2021
9.4.3 Singapore Medical Marijuana Consumption Volume from 2016 to 2021
9.4.4 Malaysia Medical Marijuana Consumption Volume from 2016 to 2021
9.4.5 Philippines Medical Marijuana Consumption Volume from 2016 to 2021
9.4.6 Vietnam Medical Marijuana Consumption Volume from 2016 to 2021
9.4.7 Myanmar Medical Marijuana Consumption Volume from 2016 to 2021
Chapter 10 Middle East Medical Marijuana Market Analysis
10.1 Middle East Medical Marijuana Consumption and Value Analysis
10.1.1 Middle East Medical Marijuana Market Under COVID-19
10.2 Middle East Medical Marijuana Consumption Volume by Types
10.3 Middle East Medical Marijuana Consumption Structure by Application
10.4 Middle East Medical Marijuana Consumption by Top Countries
10.4.1 Turkey Medical Marijuana Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Medical Marijuana Consumption Volume from 2016 to 2021
10.4.3 Iran Medical Marijuana Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Medical Marijuana Consumption Volume from 2016 to 2021
10.4.5 Israel Medical Marijuana Consumption Volume from 2016 to 2021
10.4.6 Iraq Medical Marijuana Consumption Volume from 2016 to 2021
10.4.7 Qatar Medical Marijuana Consumption Volume from 2016 to 2021
10.4.8 Kuwait Medical Marijuana Consumption Volume from 2016 to 2021
10.4.9 Oman Medical Marijuana Consumption Volume from 2016 to 2021
Chapter 11 Africa Medical Marijuana Market Analysis
11.1 Africa Medical Marijuana Consumption and Value Analysis
11.1.1 Africa Medical Marijuana Market Under COVID-19
11.2 Africa Medical Marijuana Consumption Volume by Types
11.3 Africa Medical Marijuana Consumption Structure by Application
11.4 Africa Medical Marijuana Consumption by Top Countries
11.4.1 Nigeria Medical Marijuana Consumption Volume from 2016 to 2021
11.4.2 South Africa Medical Marijuana Consumption Volume from 2016 to 2021
11.4.3 Egypt Medical Marijuana Consumption Volume from 2016 to 2021
11.4.4 Algeria Medical Marijuana Consumption Volume from 2016 to 2021
11.4.5 Morocco Medical Marijuana Consumption Volume from 2016 to 2021
Chapter 12 Oceania Medical Marijuana Market Analysis
12.1 Oceania Medical Marijuana Consumption and Value Analysis
12.2 Oceania Medical Marijuana Consumption Volume by Types
12.3 Oceania Medical Marijuana Consumption Structure by Application
12.4 Oceania Medical Marijuana Consumption by Top Countries
12.4.1 Australia Medical Marijuana Consumption Volume from 2016 to 2021
12.4.2 New Zealand Medical Marijuana Consumption Volume from 2016 to 2021
Chapter 13 South America Medical Marijuana Market Analysis
13.1 South America Medical Marijuana Consumption and Value Analysis
13.1.1 South America Medical Marijuana Market Under COVID-19
13.2 South America Medical Marijuana Consumption Volume by Types
13.3 South America Medical Marijuana Consumption Structure by Application
13.4 South America Medical Marijuana Consumption Volume by Major Countries
13.4.1 Brazil Medical Marijuana Consumption Volume from 2016 to 2021
13.4.2 Argentina Medical Marijuana Consumption Volume from 2016 to 2021
13.4.3 Columbia Medical Marijuana Consumption Volume from 2016 to 2021
13.4.4 Chile Medical Marijuana Consumption Volume from 2016 to 2021
13.4.5 Venezuela Medical Marijuana Consumption Volume from 2016 to 2021
13.4.6 Peru Medical Marijuana Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Medical Marijuana Consumption Volume from 2016 to 2021
13.4.8 Ecuador Medical Marijuana Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Medical Marijuana Business
14.1 Scotts Miracle-Gro
14.1.1 Scotts Miracle-Gro Company Profile
14.1.2 Scotts Miracle-Gro Medical Marijuana Product Specification
14.1.3 Scotts Miracle-Gro Medical Marijuana Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Canopy Growth
14.2.1 Canopy Growth Company Profile
14.2.2 Canopy Growth Medical Marijuana Product Specification
14.2.3 Canopy Growth Medical Marijuana Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 GW Pharmaceuticals
14.3.1 GW Pharmaceuticals Company Profile
14.3.2 GW Pharmaceuticals Medical Marijuana Product Specification
14.3.3 GW Pharmaceuticals Medical Marijuana Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Aurora Cannabis
14.4.1 Aurora Cannabis Company Profile
14.4.2 Aurora Cannabis Medical Marijuana Product Specification
14.4.3 Aurora Cannabis Medical Marijuana Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Aphria
14.5.1 Aphria Company Profile
14.5.2 Aphria Medical Marijuana Product Specification
14.5.3 Aphria Medical Marijuana Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 MedReLeaf
14.6.1 MedReLeaf Company Profile
14.6.2 MedReLeaf Medical Marijuana Product Specification
14.6.3 MedReLeaf Medical Marijuana Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Insys Therapeutics
14.7.1 Insys Therapeutics Company Profile
14.7.2 Insys Therapeutics Medical Marijuana Product Specification
14.7.3 Insys Therapeutics Medical Marijuana Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Sprott
14.8.1 Sprott Company Profile
14.8.2 Sprott Medical Marijuana Product Specification
14.8.3 Sprott Medical Marijuana Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 CanniMed Therapeutics
14.9.1 CanniMed Therapeutics Company Profile
14.9.2 CanniMed Therapeutics Medical Marijuana Product Specification
14.9.3 CanniMed Therapeutics Medical Marijuana Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Horizons Marijuana Life Sciences Index ETF
14.10.1 Horizons Marijuana Life Sciences Index ETF Company Profile
14.10.2 Horizons Marijuana Life Sciences Index ETF Medical Marijuana Product Specification
14.10.3 Horizons Marijuana Life Sciences Index ETF Medical Marijuana Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Medical Marijuana Market Forecast (2022-2027)
15.1 Global Medical Marijuana Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Medical Marijuana Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Medical Marijuana Value and Growth Rate Forecast (2022-2027)
15.2 Global Medical Marijuana Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Medical Marijuana Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Medical Marijuana Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Medical Marijuana Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Medical Marijuana Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Medical Marijuana Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Medical Marijuana Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Medical Marijuana Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Medical Marijuana Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Medical Marijuana Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Medical Marijuana Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Medical Marijuana Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Medical Marijuana Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Medical Marijuana Consumption Forecast by Type (2022-2027)
15.3.2 Global Medical Marijuana Revenue Forecast by Type (2022-2027)
15.3.3 Global Medical Marijuana Price Forecast by Type (2022-2027)
15.4 Global Medical Marijuana Consumption Volume Forecast by Application (2022-2027)
15.5 Medical Marijuana Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
Research Methodology:
Medical Marijuana Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|